– GEN’s Editor-in-Chief John Sterling interviews Bob More, Domain Associates, Ted Schroeder, Cadence Pharmaceuticals, and Steve Kelly, Innovive Pharmaceuticals

PodcastsResourcesBiopharmaceuticalsHealth care and economicsHealth care economicsHealth care facility, manpower, and servicesPharmacology
Previous articleSAFC Plans $10M Revamp of European Sites
Next articleVirium Pharmaceuticals Gains Rights to Southern Research Institute’s Oncology Compound
Also of Interest
Gene Network Interactions Shed Insight into Breast Cancer Onset and Development
Bruker to Acquire NanoString with $392.6M Winning Bid
StockWatch: Regeneron Shares Dip as DOJ Alleges Fraudulent Price Reporting
Launch of Nvelop Therapeutics for Delivery of Genetic Cargo, AACR Recap
Fujifilm Invests Additional $1.2 Billion to Expand its North Carolina CDMO
Vertex to Acquire Alpine Immune Sciences for $4.9B, Broadening Kidney Drug Pipeline
Related Media
Carl Icahn States His Case for Change at Illumina on "Close to the Edge"
Emerging Markets Collaborate to Succeed in Post-Pandemic World
Global Single-Use Network Support Assurance of Supply
Reporter's Notebook: Opening Day at the J.P. Morgan Healthcare Conference
Resins Address Downstream Purification Concerns
Materials Sourcing: Precautions and Improvements for Cell and Gene Therapies